185 related articles for article (PubMed ID: 6706305)
1. Franco-Belgian cooperative study of ursodeoxycholic acid in the medical dissolution of gallstones: a double-blind, randomized, dose-response study, and comparison with chenodeoxycholic acid.
Erlinger S; Le Go A; Husson JM; Fevery J
Hepatology; 1984; 4(2):308-14. PubMed ID: 6706305
[TBL] [Abstract][Full Text] [Related]
2. Treatment of radiolucent gallstones with CDCA or UDCA. A multicenter trial.
Polli EE; Bianchi PA; Conte D; Sironi L
Digestion; 1981; 22(4):185-91. PubMed ID: 7030835
[TBL] [Abstract][Full Text] [Related]
3. Ursodeoxycholic acid vs. chenodeoxycholic acid as cholesterol gallstone-dissolving agents: a comparative randomized study.
Roda E; Bazzoli F; Labate AM; Mazzella G; Roda A; Sama C; Festi D; Aldini R; Taroni F; Barbara L
Hepatology; 1982; 2(6):804-10. PubMed ID: 7141392
[TBL] [Abstract][Full Text] [Related]
4. Retrospective comparison of 'Cheno' and 'Urso' in the medical treatment of gallstones.
Meredith TJ; Williams GV; Maton PN; Murphy GM; Saxton HM; Dowling RH
Gut; 1982 May; 23(5):382-9. PubMed ID: 7076015
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. A double-blind controlled study.
Fromm H; Roat JW; Gonzalez V; Sarva RP; Farivar S
Gastroenterology; 1983 Dec; 85(6):1257-64. PubMed ID: 6354826
[TBL] [Abstract][Full Text] [Related]
6. Different effects of chenodeoxycholic acid and ursodeoxycholic acid on serum lipoprotein concentrations in patients with radiolucent gallstones.
Leiss O; von Bergmann K
Scand J Gastroenterol; 1982 Aug; 17(5):587-92. PubMed ID: 7178821
[TBL] [Abstract][Full Text] [Related]
7. A combination of chenodeoxycholic acid and ursodeoxycholic acid is more effective than either alone in reducing biliary cholesterol saturation.
Podda M; Zuin M; Dioguardi ML; Festorazzi S; Dioguardi N
Hepatology; 1982; 2(3):334-9. PubMed ID: 7076116
[TBL] [Abstract][Full Text] [Related]
8. [Oral dissolving treatment of gallbladder calculi: focus in 1989].
Erlinger S
Ann Chir; 1989; 43(6):417-9. PubMed ID: 2817740
[TBL] [Abstract][Full Text] [Related]
9. Clinical studies on cheno- and ursodeoxycholic acid treatment for gallstone dissolution.
Iwamura K
Hepatogastroenterology; 1980 Feb; 27(1):26-34. PubMed ID: 7203354
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of bile acid therapy for gallstone dissolution: a meta-analysis of randomized trials.
May GR; Sutherland LR; Shaffer EA
Aliment Pharmacol Ther; 1993 Apr; 7(2):139-48. PubMed ID: 8485266
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of a combination of chenodeoxycholic acid and ursodeoxycholic acid for gallstone dissolution: a comparison with ursodeoxycholic acid alone.
Podda M; Zuin M; Battezzati PM; Ghezzi C; de Fazio C; Dioguardi ML
Gastroenterology; 1989 Jan; 96(1):222-9. PubMed ID: 2642440
[TBL] [Abstract][Full Text] [Related]
12. Comparison of effects of chenodeoxycholic and ursodeoxycholic acid and their combination on biliary lipids in obese patients with gallstones.
Zuin M; Petroni ML; Grandinetti G; Crosignani A; Bertolini E; Battezzati PM; Podda M
Scand J Gastroenterol; 1991 Mar; 26(3):257-62. PubMed ID: 1853147
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and indications of ursodeoxycholic acid treatment for dissolving gallstones. A multicenter double-blind trial. Tokyo Cooperative Gallstone Study Group.
Gastroenterology; 1980 Mar; 78(3):542-8. PubMed ID: 6985882
[TBL] [Abstract][Full Text] [Related]
14. Controlled trial of chenodeoxycholic therapy for radiolucent gallstones. A multicenter study.
Gerolami A; Sarles H; Brette R; Paraf A; Rautureau J; Debray C; Bermann C; Etienne JP; Chaput JC; Petite JP
Digestion; 1977; 16(4):299-307. PubMed ID: 355026
[TBL] [Abstract][Full Text] [Related]
15. [Combined therapy with chenodeoxycholic acid and ursodeoxycholic acid of radiolucent biliary lithiasis].
Pérez Aguilar F; Breto M; del Val A; Berenguer J
An Med Interna; 1989 Mar; 6(3):119-24. PubMed ID: 2491184
[TBL] [Abstract][Full Text] [Related]
16. [Dissolution of biliary calculi with CDCA and UDCA].
Sugata F
Nihon Rinsho; 1984 Jul; 42(7):1683-9. PubMed ID: 6387220
[No Abstract] [Full Text] [Related]
17. Chenodeoxycholic acid and ursodeoxycholic acid effects in endogenous hypertriglyceridemias. A controlled double-blind trial.
Carulli N; Ponz de Leon M; Podda M; Zuin M; Strata A; Frigerio G; Digrisolo A
J Clin Pharmacol; 1981 Oct; 21(10):436-42. PubMed ID: 7031100
[TBL] [Abstract][Full Text] [Related]
18. Medical dissolution of gallstones by ursodeoxycholic acid: a clinical trial on 14 patients.
Lin JT; Wang JT; Wang TH; Su CT
Taiwan Yi Xue Hui Za Zhi; 1989 Apr; 88(4):370-6. PubMed ID: 2794937
[TBL] [Abstract][Full Text] [Related]
19. Lack of response to chenodeoxycholic acid in obese and non-obese patients. Role of cholesterol synthesis and possible response to ursodeoxycholic acid.
Maton PN; Murphy GM; Dowling RH
Gut; 1980 Dec; 21(12):1082-6. PubMed ID: 7461467
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of ursodeoxycholic acid for dissolution of gallstone fragments: comparison with the combination of ursodeoxycholic acid and chenodeoxycholic acid.
Sackmann M; Pauletzki J; Aydemir U; Holl J; Sauerbruch T; Hasford J; Paumgartner G
Hepatology; 1991 Dec; 14(6):1136-41. PubMed ID: 1959863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
